Selected as Technology Pioneer in 2008 by the World Economic Forum, Anecova is initiating the market deployment of its AneVivo based Natural Fertilization procedure in Poland with Gyncentrum Clinic in Katowice.
After several years of R&D and clinical development, Anecova has developed a more natural approach to assisted reproductive technology with the development of a porous capsule device allowing bi-directional passage of fluids, nutrients, and noncellular components, to enable interaction between the embryos and the maternal environment. It allows fertilization and early embryo development in the maternal environment.
Martin Velasco, Founder, Chairman and CEO of Anecova, says: “Gyncentrum Clinic, under the leadership of Pawel Czerwinski, CEO and President of the Board, and Dr. Dariusz Mercik, Medical Director, has developed a unique level of excellence in patient care in IVF in Poland, combined with state of the art, innovative, patient research. Gyncentrum Clinic has consistently demonstrated a very dynamic development over the past years. We are delighted that Gyncentrum Clinic will be offering to its patients the Natural Fertilization procedure based on our AneVivo device”.
Gyncentrum Clinic is one of the top fertility treatment facilities in Poland. With a team of 40 highly qualified medical specialists in the field of gynecology, endocrinology, urology, immunology, psychology and dietetics.
Dr. Dariusz Mercik, Medical Director of Gyncentrum Clinic says: “The AneVivo device allows fertilization and early embryo development to happen in the mother’s womb rather than in the laboratory. Fertility and early embryos growth happen in a more physiological environment, receiving nutrition and signals from the mother rather than from the culture fluids used in the laboratory. There is increasing evidence that long term health of IVF babies may benefit from reducing the time spent in laboratory conditions. Studies have also shown that this approach, which allows the embryo and the mother to signal to each other, may result in the mother being better prepared and more receptive for embryo implantation. The early results of this innovative procedure are very encouraging.”
Anecova is a Swiss medical device company based at the EPFL Innovation Park in Lausanne. Anecova is working with world leading scientists and clinicians in the area of Assisted Reproductive Technology (ART) with the objective of developing more natural approaches to Assisted Reproductive Techniques (ART). The company is ISO certified (9001 and 13485) and its AneVivo device is European Certified (CE MARK) and has also received the approval of several regulators in Europe, including the HFEA in the UK. Anecova has been working in the past years in the development of a device allowing the fertilization and embryo development in the maternal environment instead of in the laboratory. AneVivo, its first device, allows clinics to offer a Natural Fertilization and Natural Development procedures to their patients. Anecova is starting the commercialization of AneVivo through leading IVF clinics, initially in the UK with Complete Fertility Center, Southampton, IVI Bilbao and IVI Barcelona, part of IVI Group, SISMeR in Bologne and Gyncentrum Clinic in Katowice. Anecova was granted the Technology Pioneer award in 2008 at the World Economic Forum.
For more information go to www.anecova.com.
About Gyncentrum Fertility Clinic
Gyncentrum proves cutting-edge treatments with the most advanced techniques of assisted reproductive treatment available on the market, including treatments with the newest method of classic In Vitro, which increases the probability of success, such as ICSI and IMSI. As one of the pioneer fertility clinics in Poland, Gyncentrum introduced PGD diagnosis, which can be used to test, identify and eliminate the risk of transmission of over 100 genetic conditions and diseases from parents to child. The quality of a medical professional is dictated not only by career longevity but also by that professional’s acknowledgement by their peers as shown by certification, awards, commencements and consistent international collaboration. The numerous medical professionals who serve as part of the Gyncentrum Clinic in Poland embody this definition of quality. Additionally, Gyncentrum has established a reputation as a medical tourism specialist. International patients who visit Poland from abroad are well taken care of through the process. From pre-treatment planning and preparation to arrival at the facility, treatment and departure, step-by-step information is provided and helpful customer service remains available to patients at all times to ensure that the stay in Poland is unforgettable and as stress-free as possible. Gyncentrum patients have also benefitted from the National Health Program: “Infertility Treatment Using In Vitro Fertilization for the years 2013-2016”, which has helped thousands of patients undergo successful treatment. Patients are also given access to the International Sperm and Egg Bank. Gyncentrum’s access to this egg and sperm donation program allows patients who can’t conceive naturally achieve their dream of childbirth through the generosity of an international network of donors.
Voxia communication SA
+41 78 777 87 77